DAYONIX PHARMA LIMITEDActive
Key figures
Like most small UK companies, DAYONIX PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 24,317 | — | — | — | — |
| Total assets | 131,380 | 87,013 | 202,571 | 445,492 | 219,533 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | -512,047 | -593,652 | -621,995 | -684,254 | -688,844 |
| Average number of employees | 4 | 1 | 3 | 3 | 4 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: DAYONIX PHARMA LIMITED
Company
DAYONIX PHARMA LIMITED is a private limited company registered with Companies House under company number 11535316. It was incorporated on 24 Aug 2018. Its status is active. The registered office is in Epsom (KT19). Its nature of business (SIC 2007) is manufacture of homogenized food preparations and dietetic food (10860), manufacture of other food products n.e.c. (10890), non-specialised wholesale trade (46900), retail sale via mail order houses or via Internet (47910).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files micro-entity accounts. Net assets were −£688,844, down 0.7% on the previous year. The company had an average of 4 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 May 2027. The next confirmation statement is due by 28 Jan 2027.